San
Francisco, 10 December 2018: The global biopharmaceuticals contract manufacturing market size is expected to reach USD 21.7 billion
by 2025, according to a new report by Grand View Research, Inc., registering a
CAGR of 7.5% during the forecast period.
Growing biopharmaceutical pipeline and lack
of adequate manufacturing capabilities are two key factors driving partnerships
between large molecule manufacturers and contract manufacturing organizations
(CMOs). Contract manufacturers are engaged in broadening their service
portfolio to meet companies’ demand with respect to regulatory standards and
new services.
Reliance
of companies on CMOs for production of biologics and biosimilars is expected to
rise over the forecast period as a consequence of changes adopted by CMOs. This
is evident through growing investments in collaborations of companies with CMOs
as well as continuous efforts taken up for broadening service portfolios.
The
growth of CMOs is highly dependent on promising opportunities offered by the
biopharmaceutical industry, bioprocessing industry, and contract service
industry. Expansion of fill-and-finish services and increasing robustness of
venture capital investments in the life science sector are important
opportunities that are anticipated to drive the market.
Access
Research Report of Biopharmaceuticals
Contract Manufacturing Market @ www.grandviewresearch.com/industry-analysis/biopharmaceuticals-contract-manufacturing-market
Further key findings
from the report suggest:
· Based
on source, mammalian-based biopharmaceutical contract manufacturing captured
the largest market share owing to high penetration of mammalian expression
systems for biologics development
· By
service, upstream and downstream services accounted for the largest revenue
share. Complexities associated with these steps pronounces demand for
established contract manufacturers to ensure manufacturing processes compliant
with regulatory standards
· Biologics
contract manufacturing dominated the market based on product owing to higher
demand for biologics production. However, the biosimilar segment is slated to
exhibit a lucrative CAGR due to cost-saving advantages associated with its
development
· Presence
of effective regulatory framework for biologics development in U.S. has
resulted in North America market accounting for the dominant share in 2017.
However, Asia Pacific is expected to emerge as the fastest growing regional
market, with developing economies expanding at a substantial pace and
incorporating developments to sustain the competition
· Several
international companies are seeking outsourcing of biopharmaceutical production
to Asian countries owing to continuous expansion of Asian CMOs that offer
services at a reduced price, compared to service providers based in western
countries
· Some
of the key service providers are Boehringer Ingelheim GmbH; Lonza; Samsung
BioLogics; and FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
Browse more
reports of this category by Grand View Research at: www.grandviewresearch.com/industry/biotechnology
Grand
View Research has segmented the global biopharmaceuticals contract
manufacturing market on the basis of source, service, product, and region:
Biopharmaceuticals Contract Manufacturing
Source Outlook (Revenue, USD Million, 2014 - 2025)
·
Mammalian
·
Non-mammalian
Biopharmaceuticals Contract Manufacturing
Service Outlook (Revenue, USD Million, 2014 - 2025)
·
Process
Development
·
Fill
& Finish Operations
·
Analytical
& QC Studies
·
Packaging
Biopharmaceuticals Contract Manufacturing
Product Outlook (Revenue, USD Million, 2014 - 2025)
·
Biologics
·
Biosimilars
Biopharmaceuticals Contract Manufacturing
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North
America
·
Europe
·
Asia
Pacific
·
Latin
America
·
Middle
East & Africa
Access Press Release of Biopharmaceuticals
Contract Manufacturing Market@ www.grandviewresearch.com/press-release/global-biopharmaceuticals-contract-manufacturing-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment